logo
Activate Welcomes 47 New Fellows

Activate Welcomes 47 New Fellows

Business Wire5 days ago
BERKELEY, Calif.--(BUSINESS WIRE)--Activate, the nonprofit organization that helps science entrepreneurs transform breakthrough ideas into advanced hard tech companies, today announced the next cohort of 47 scientists and engineers who are joining the Activate Fellowship. The 39 companies of Cohort 2025 are developing technologies across 14 industries. This new cohort represents 29 cities and nine states in the U.S., spanning Activate's four hub communities – Berkeley, Boston, Houston, and New York – as well as Activate Anywhere, the remote-based community that includes fellows across the U.S.
'Science entrepreneurship is the origin story of tomorrow's industries,' said Cyrus Wadia, CEO of Activate. 'The U.S. has long been a world center for science leadership and technological advancement. When it comes to solving the world's biggest challenges, hard tech innovation is how we unlock the best solutions. From infrastructure to energy to agriculture, these Activate Fellows are the bold thinkers who are building the next generation of science-focused companies to lead us into the future.'
The selection process attracted applications from across the nation and demonstrated trends in future hard tech innovation across a number of industries including semiconductors, AI, critical minerals, energy security, agriculture, infrastructure, and more. Activate's selection committees include some of the world's top subject matter experts across the fields of quantum, robotics, biology, agriculture, energy, direct air capture, and many others, ensuring that the technologies and startups that fellows establish are truly novel.
Activate continues to expand its region of impact even further, now adding its first fellow in Ohio and making its total geographic reach 25 states. The Activate Anywhere cohort, first launched by the U.S. National Science Foundation, includes even more fellows in innovation ecosystems like Michigan and Colorado, in addition to fellows in the core Activate Communities based out of California, Massachusetts, New York, and Texas. This year's cohort also includes increased emphasis to onshore domestic semiconductor manufacturing funded through the NIST CHIPS Research and Development (R&D) Office and the National Science Foundation.
This marks the 11th cohort for Activate, which was founded in 2015. Over the past decade, Activate Fellows have created 236 companies, of which 97 percent are still active. These companies have raised over $4B in follow-on funding and created almost 3,000 new jobs across the U.S. This year's fellows were selected from over 900 applications, making this the most competitive cohort to date. As a nonprofit organization, Activate relies on partnerships with generous funders, from government to private philanthropy, to make the fellowship possible.
ABOUT ACTIVATE
Founded in 2015, Activate empowers scientists and engineers to reinvent the world by launching startups to address the most pressing global challenges. Working between government, philanthropy, universities, and the private sector, Activate transforms scientists and engineers into high-impact entrepreneurs through the Activate Fellowship, a two-year immersive experience that equips science entrepreneurs with the skills, networks, infrastructure, and funding they need to quickly and effectively bring their groundbreaking research to market. Activate is a 501(c)(3) nonprofit and does not charge any fee nor equity for fellows to participate. Activate's entrepreneurial fellowship model originated at Cyclotron Road, founding Activate partner and the first U.S. Department of Energy's Lab-Embedded Entrepreneurship Program (LEEP) started at Lawrence Berkeley National Laboratory. Activate supports fellows in communities across the United States: Activate Berkeley, Activate Boston, Activate New York, Activate Houston, and Activate Anywhere. Learn more at Activate.org.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Central Pacific Financial Corp. Announces Conference Call to Discuss Second Quarter 2025 Financial Results
Central Pacific Financial Corp. Announces Conference Call to Discuss Second Quarter 2025 Financial Results

Business Wire

time8 hours ago

  • Business Wire

Central Pacific Financial Corp. Announces Conference Call to Discuss Second Quarter 2025 Financial Results

HONOLULU--(BUSINESS WIRE)--Central Pacific Financial Corp. (NYSE: CPF), parent company of Central Pacific Bank, will release its second quarter 2025 earnings on July 25, 2025, before the open of the New York Stock Exchange. Management will review the results by conference call and live audio webcast beginning at 2:00 p.m. Eastern Time (8:00 a.m. Hawaii Time) on July 25, 2025. Interested parties may listen to the conference by calling 1-800-715-9871 (conference ID: 6299769), or by listening to the webcast on the company's investor relations website at A replay of the call will be available through August 24, 2025 by dialing 1-800-770-2030 (conference ID: 6299769) and on the company's website. About Central Pacific Financial Corp. Central Pacific Financial Corp. is a Hawaii-based bank holding company with approximately $7.41 billion in assets as of March 31, 2025. Central Pacific Bank, its primary subsidiary, operates 27 branches and 55 ATMs in the State of Hawaii. For additional information, please visit the Company's website at: Equal Housing Lender Member FDIC NYSE Listed CPF

Kirby McInerney LLP Urges Investors in DoubleVerify Holdings, Inc. (DV) to Inquire About Their Rights in Class Action Lawsuit
Kirby McInerney LLP Urges Investors in DoubleVerify Holdings, Inc. (DV) to Inquire About Their Rights in Class Action Lawsuit

Business Wire

time8 hours ago

  • Business Wire

Kirby McInerney LLP Urges Investors in DoubleVerify Holdings, Inc. (DV) to Inquire About Their Rights in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of the July 21, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired DoubleVerify Holdings, Inc. ('DoubleVerify' or the 'Company') (NYSE:DV) securities during the period from November 10, 2023, through February 27, 2025 ('the Class Period'). [ LEARN MORE ABOUT THE CLASS ACTION ] On February 28, 2024, DoubleVerify issued lower revenue growth expectations for the first quarter of 2024 due to 'a slow start by brand advertisers and a slow ramp by recently signed new large customers.' On this news, the price of DoubleVerify shares declined by $8.25 per share, or approximately 21%, from $39.24 per share on February 28, 2024, to close at $30.89 on February 29, 2024. On May 7, 2024, in connection with its first quarter 2024 earnings report, DoubleVerify surprised analysts by cutting its full-year 2024 revenue outlook due to customers that were pulling back on their ad spending. On this news, the price of DoubleVerify shares declined by $11.79 per share, or approximately 38%, from $30.57 per share on May 7, 2024, to close at $18.78 on May 8, 2024. Then, on February 27, 2025, when DoubleVerify reported lower-than-expected fourth quarter 2024 sales and earnings due in part to reduced customer spending, DoubleVerify also disclosed that the shift of ad dollars from open exchanges to closed platforms was negatively impacting the Company. On this news, the price of DoubleVerify shares declined by $7.83, or approximately 36%, from $21.73 per share on February 27, 2025, to close at $13.90 on February 28, 2025. Finally, on March 28, 2025, market research company Adalytics Research, LLC released a report claiming that DoubleVerify's web advertisement verification and fraud protection services are ineffective, and that DoubleVerify customers are regularly billed for ad impressions served to declared bots operating out of known data center server farms. On the same day, The Wall Street Journal reported that DoubleVerify regularly misses detection of nonhuman traffic in contradiction to the Company's claims that it helps brand avoid serving ads to nonhuman bot accounts. If you purchased or otherwise acquired DoubleVerify securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@ or fill out the form below, to discuss your rights or interests with respect to these matters without any cost to you. [ CONTACT FORM ] Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

time9 hours ago

  • Business Wire

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation ('Quanterix' or the 'Company') (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that on July 8, 2025, the Company approved inducement grants of restricted stock units ('RSUs') representing 267,269 shares of Quanterix common stock to twenty employees newly-hired in connection with the acquisition of Akoya Biosciences, Inc. The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with the Company. The RSUs vest in full on the one year anniversary of the grant date, subject to the applicable individual's continued employment with the Company or one of its subsidiaries through the vesting date. About Quanterix Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa ® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company ®, adding multiplexed tissue imaging with single-cell resolution to its portfolio. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics. Learn more at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store